These changes cause trypsinogen activation, which is entirely consistent with our previous prediction by software, which suggested that the down-regulation of LAMP2 and CTSL1 may together promote the occurrence of AP. The gene discussed is LAMP2; the disease is alkaline phosphatase measurement.